Recent Finacing
Recent Raise
Seaport Therapeutics is a biotech company leveraging its proprietary Glyph platform to create orally delivered therapies that target the intestinal lymphatic system.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Seaport Therapeutics.
